Showing results (101-110 of 586) with videos related to
Sort By:
Pageof 59
European Heart Journal|March 9, 2013
New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysisJonas Oldgren, Lars Wallentin, John H Alexander, et al.The American Journal of Medicine|August 26, 2003
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trialStefan James, Paul Armstrong, Robert Califf, et al.Sleep Medicine|January 31, 2012
Daylight saving time shifts and incidence of acute myocardial infarction--Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)Imre Janszky, Staffan Ahnve, Rickard Ljung, et al.European Heart Journal|February 9, 2006
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome surveyAnnika Rosengren, Lars Wallentin, Maarten Simoons, et al.Journal of the American Heart Association|January 14, 2026
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart FailureTymon Pol, Johan Lindbäck, Jonas Oldgren, et al.European Heart Journal|June 30, 2007
Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in womenCynthia M Westerhout, Michael S Lauer, Stefan James, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)Anders Sahlén, Christoph Varenhorst, Bo Lagerqvist, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2011
Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trialMasatsugu Hori, Stuart J Connolly, Michael D Ezekowitz, et al.American Heart Journal|June 24, 2010
Cockcroft-Gault is better than the Modification of Diet in Renal Disease study formula at predicting outcome after a myocardial infarction: data from the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)Karolina Szummer, Pia Lundman, Stefan H Jacobson, et al.European Heart Journal. Quality of Care & Clinical Outcomes|October 16, 2022
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)Gorav Batra, Suleman Aktaa, A John Camm, et al.Pageof 59